Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Novel aspects of Sjögren's syndrome in 2012.

Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y.

BMC Med. 2013 Apr 4;11:93. doi: 10.1186/1741-7015-11-93. Review.

2.

[Vasculopathy in Sjögren's syndrome].

Feist E, Hermann KG, Dankof A.

Z Rheumatol. 2009 Jun;68(4):305-11. doi: 10.1007/s00393-008-0400-8. Review. German.

PMID:
19357858
3.

Reactivation of Epstein-Barr virus in Sjögren's syndrome.

Fox RI, Luppi M, Kang HI, Pisa P.

Springer Semin Immunopathol. 1991;13(2):217-31. Review.

PMID:
1664987
4.

Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review.

Kivity S, Arango MT, Ehrenfeld M, Tehori O, Shoenfeld Y, Anaya JM, Agmon-Levin N.

J Autoimmun. 2014 Jun;51:17-22. doi: 10.1016/j.jaut.2014.02.008. Epub 2014 Mar 15.

PMID:
24637076
5.

Sjögren's syndrome.

Fox RI.

Curr Opin Rheumatol. 1995 Sep;7(5):409-16. Review.

PMID:
8519614
6.

Advances in the understanding and treatment of systemic complications in Sjögren's syndrome.

Brito-Zerón P, Ramos-Casals M; EULAR-SS task force group.

Curr Opin Rheumatol. 2014 Sep;26(5):520-7. doi: 10.1097/BOR.0000000000000096. Review.

PMID:
25050925
7.

Epstein-Barr virus as an etiological agent in primary Sjögren's syndrome.

Whittingham S, McNeilage LJ, Mackay IR.

Med Hypotheses. 1987 Apr;22(4):373-86.

PMID:
3035352
8.

Sjögren's syndrome, the old and the new.

Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y.

Best Pract Res Clin Rheumatol. 2012 Feb;26(1):105-17. doi: 10.1016/j.berh.2012.01.012. Review.

PMID:
22424197
9.

Conventional therapy of Sjogren's syndrome.

Mavragani CP, Moutsopoulos HM.

Clin Rev Allergy Immunol. 2007 Jun;32(3):284-91. Review.

PMID:
17992595
10.

Sjögren's syndrome in dermatology.

Fox RI, Liu AY.

Clin Dermatol. 2006 Sep-Oct;24(5):393-413. Review.

PMID:
16966020
11.

Low levels of vitamin-D are associated with neuropathy and lymphoma among patients with Sjögren's syndrome.

Agmon-Levin N, Kivity S, Tzioufas AG, López Hoyos M, Rozman B, Efes I, Shapira Y, Shamis A, Amital H, Youinou P, Shoenfeld Y.

J Autoimmun. 2012 Sep;39(3):234-9. doi: 10.1016/j.jaut.2012.05.018. Epub 2012 Jul 24.

PMID:
22835660
12.

Current and potential treatments for primary Sjögren's syndrome.

Mariette X.

Joint Bone Spine. 2002 Jun;69(4):363-6. Review.

PMID:
12184431
13.

Autoantibodies against a 72-kDa ductal cell membrane glycoprotein in a patient affected by Sjögren's syndrome and gastric MALT lymphoma.

Folli F, Perego L, Ponzoni M, Girardi AM, Bosi E, Ferreri AJ, Bellone M, Sabbadini MG, Vicari AM, Trusolino L.

Ann Hematol. 2002 Oct;81(10):597-602. Epub 2002 Sep 24. Erratum in: Ann Hematol. 2003 Mar;82(3):203.

PMID:
12424543
14.

Antibodies to Epstein-Barr virus and cytomegalovirus in primary Sjogren's syndrome.

Origgi L, Hu C, Bertetti E, Asero R, D'Agostino P, Radelli L, Riboldi P.

Boll Ist Sieroter Milan. 1988;67(4):265-74.

PMID:
2856043
15.

Reactivation of Epstein-Barr virus in Sjögren's syndrome.

Fox RI, Howell FV.

Ric Clin Lab. 1987 Oct-Dec;17(4):273-7.

PMID:
2830658
16.

One year in review 2016: Sjögren's syndrome.

Ferro F, Vagelli R, Bruni C, Cafaro G, Marcucci E, Bartoloni E, Baldini C.

Clin Exp Rheumatol. 2016 Mar-Apr;34(2):161-71. Epub 2016 Apr 13. Review.

17.

Type I interferons in Sjögren's syndrome.

Yao Y, Liu Z, Jallal B, Shen N, Rönnblom L.

Autoimmun Rev. 2013 Mar;12(5):558-66. doi: 10.1016/j.autrev.2012.10.006. Epub 2012 Nov 30. Review.

18.

Potential role of Epstein-Barr virus in Sjögren's syndrome.

Fox RI, Chilton T, Scott S, Benton L, Howell FV, Vaughan JH.

Rheum Dis Clin North Am. 1987 Aug;13(2):275-92. Review.

PMID:
2827246
20.

[Sjögren's syndrome].

Umehara H, Sawaki T, Kawanami T, Masaki Y, Fukushima T.

Nihon Rinsho. 2009 Mar;67(3):511-6. Review. Japanese.

PMID:
19280925

Supplemental Content

Support Center